A detailed history of Mid West One Financial Group, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Mid West One Financial Group, Inc. holds 36,748 shares of ABBV stock, worth $6.45 Million. This represents 1.01% of its overall portfolio holdings.

Number of Shares
36,748
Previous 36,820 0.2%
Holding current value
$6.45 Million
Previous $6.32 Million 14.9%
% of portfolio
1.01%
Previous 1.15%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$163.84 - $199.33 $11,796 - $14,351
-72 Reduced 0.2%
36,748 $7.26 Million
Q2 2024

Aug 15, 2024

SELL
$154.79 - $180.76 $44,889 - $52,420
-290 Reduced 0.78%
36,820 $6.32 Million
Q1 2024

May 15, 2024

SELL
$159.82 - $182.1 $328,909 - $374,761
-2,058 Reduced 5.25%
37,110 $6.76 Million
Q4 2023

Feb 14, 2024

BUY
$137.6 - $154.97 $198,694 - $223,776
1,444 Added 3.83%
39,168 $6.07 Million
Q3 2023

Nov 14, 2023

BUY
$133.59 - $154.65 $170,995 - $197,952
1,280 Added 3.51%
37,724 $5.62 Million
Q2 2023

Aug 14, 2023

BUY
$132.51 - $164.9 $461,267 - $574,016
3,481 Added 10.56%
36,444 $4.91 Million
Q1 2023

May 15, 2023

SELL
$144.61 - $166.54 $49,890 - $57,456
-345 Reduced 1.04%
32,963 $5.25 Million
Q4 2022

Feb 14, 2023

SELL
$138.31 - $165.87 $369,149 - $442,707
-2,669 Reduced 7.42%
33,308 $5.39 Million
Q3 2022

Nov 14, 2022

BUY
$134.21 - $153.93 $40,531 - $46,486
302 Added 0.85%
35,977 $4.83 Million
Q2 2022

Aug 16, 2022

BUY
$137.62 - $174.96 $135,693 - $172,510
986 Added 2.84%
35,675 $5.46 Million
Q1 2022

May 17, 2022

SELL
$131.98 - $163.75 $318,731 - $395,456
-2,415 Reduced 6.51%
34,689 $5.62 Million
Q4 2021

Feb 15, 2022

SELL
$107.43 - $135.93 $276,847 - $350,291
-2,577 Reduced 6.49%
37,104 $5.02 Million
Q3 2021

Nov 15, 2021

BUY
$106.4 - $120.78 $58,200 - $66,066
547 Added 1.4%
39,681 $4.28 Million
Q2 2021

Aug 17, 2021

SELL
$105.21 - $117.21 $139,929 - $155,889
-1,330 Reduced 3.29%
39,134 $4.41 Million
Q1 2021

May 18, 2021

BUY
$102.3 - $112.62 $1.31 Million - $1.44 Million
12,829 Added 46.42%
40,464 $4.38 Million
Q4 2020

Feb 17, 2021

SELL
$80.49 - $108.67 $869,774 - $1.17 Million
-10,806 Reduced 28.11%
27,635 $2.96 Million
Q3 2020

Nov 17, 2020

BUY
$85.91 - $100.83 $546,387 - $641,278
6,360 Added 19.82%
38,441 $3.37 Million
Q2 2020

Aug 17, 2020

SELL
$73.37 - $98.18 $333,319 - $446,031
-4,543 Reduced 12.4%
32,081 $3.15 Million
Q1 2020

May 14, 2020

SELL
$64.5 - $97.79 $2,580 - $3,911
-40 Reduced 0.11%
36,624 $2.79 Million
Q4 2019

Feb 14, 2020

SELL
$72.13 - $90.25 $13,993 - $17,508
-194 Reduced 0.53%
36,664 $3.25 Million
Q3 2019

Nov 14, 2019

SELL
$62.98 - $75.72 $25,506 - $30,666
-405 Reduced 1.09%
36,858 $2.79 Million
Q2 2019

Aug 15, 2019

BUY
$65.7 - $83.98 $2.45 Million - $3.13 Million
37,263 New
37,263 $2.71 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $310B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Mid West One Financial Group, Inc. Portfolio

Follow Mid West One Financial Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mid West One Financial Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mid West One Financial Group, Inc. with notifications on news.